James Niblock

James Niblock is an accomplished professional in the healthcare and pharmaceutical sectors, currently serving as the Director of Managed Access Programs at Thermo Fisher Scientific since October 2025. Prior roles include Sr. Program Manager for Medical Affairs, Early Access at Alnylam Pharmaceuticals, and Expanded Access Advisor at PANTHERx Rare Pharmacy, where James significantly contributed to the implementation of patient-centered Expanded Access Programs. With previous experience as an Expanded Access Program Manager at Karyopharm Therapeutics Inc., James managed programs in over 35 countries. Early career roles at Caligor Coghlan Pharma Services and Global Language Solutions focused on program management and business development within the life sciences. James holds a Master of Arts degree in French and Spanish from The University of Edinburgh.